Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:appliesTo |
gptkb:gene_therapy
gptkb:enzyme_replacement_therapy autoimmune disease treatment |
| gptkbp:clinicalTrialPhase |
gptkb:SEL-212
gptkb:SEL-302 |
| gptkbp:contains |
gptkb:rapamycin
|
| gptkbp:developedBy |
gptkb:Selecta_Biosciences
|
| gptkbp:enables |
repeated dosing of biologic therapies
|
| gptkbp:headquartersLocation |
gptkb:Watertown,_Massachusetts,_USA
|
| gptkbp:mechanismOfAction |
modulation of immune response
|
| gptkbp:technology |
nanoparticle-based
|
| gptkbp:usedFor |
immune tolerance induction
mitigation of anti-drug antibodies |
| gptkbp:bfsParent |
gptkb:Selecta_Biosciences
|
| gptkbp:bfsLayer |
5
|
| https://www.w3.org/2000/01/rdf-schema#label |
ImmTOR platform
|